Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allefin topical gel versus placebo in histamine-induced skin reactions in healthy volunteers
2018-004502-26Phase 2Completed
- Sponsor
- Hasco-Lek
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Allefin in pruritus, contact hypersensitivity and inflammatory skin lesion (2 arms), sponsored by Hasco-Lek. Primary endpoint: Difference in area under the curve for itch intensity. Started Apr 2019; status: completed.
02
Drugs
Allefin
03
Conditions
prurituscontact hypersensitivityinflammatory skin lesion
Beyond the preview
Go deeper on 2018-004502-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004502-26.